# Faraday Pharmaceuticals

**Canonical:** https://apis.io/providers/faraday-pharmaceuticals/  
**APIs profiled:** 0

Faraday Pharmaceuticals, Inc. was a Seattle, Washington clinical-stage biopharmaceutical company founded in 2014 as a spinout of Fred Hutchinson Cancer Center, built on the elemental-reducing-agent research of Dr. Mark Roth. It developed therapies intended to prevent and treat cardiac and skeletal muscle loss after acute critical illness, led by FDY-5301 — a proprietary intravenous formulation of sodium iodide designed to neutralize reactive oxygen species and limit reperfusion injury in patients undergoing percutaneous coronary intervention for anterior ST-elevation myocardial infarction (STEMI). The company raised roughly $120M from an investor group led by ARCH Venture Partners and Polaris Partners. Its Phase 3 trial read out in late 2025 and failed to meet its primary or secondary endpoints, and Faraday announced in February 2026 that it had ceased operations and was winding down the business. Faraday never operated a developer program, public API, SDK, or machine-readable specification, and its faradaypharma.com website is no longer served. This profile is retained as a historical record; there is no API surface to enrich.

## Kin Score — 5.1 / 100 (minimal)

Scored 2026-08-17 under rubric 0.11.0. Trend: flat (+0.0 from 5.1).

| Facet | Score |
|---|---|
| Discoverability | 46.3 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |

Regulatory layer — **Health**: 7.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Security (1)

- **Faraday Pharmaceuticals Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Company, Pharmaceuticals, Biotechnology, Life Sciences, Clinical Trials, Clinical Stage, Cardiology, Drug Development, Defunct

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/faraday-pharmaceuticals/). Scores are computed from the provider's own public artifacts under a published rubric.